Concepedia

Publication | Open Access

Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients

DOIFull Paper Access

45

Citations

33

References

2017

Year

Arthur E. Frankel, Uğur Eskiocak, Jennifer G. Gill, Stacy W. Yuan, Vijayashree Ramesh, Thomas Froehlich, Chul Ahn, Sean J. Morrison
Neoplasia

Abstract

Digoxin plus trametinib is well tolerated and achieves a high rate of disease control in BRAF wild-type metastatic melanoma patients.

References

YearCitations

Page 1